BEHAVIOURAL ANTAGONISM TO A NEW PSYCHOTOMIMETIC: JB--329.
D000166:Acridines; D000818:Animals; D001522:Behavior, Animal; D001713:Biphenyl Compounds; D004285:Dogs; D004338:Drug Combinations; D005449:Fluorenes; D006016:Glycolates; D006213:Hallucinogens; D008333:Mandelic Acids; D010600:Pharmacology; D010880:Piperidines; D011725:Pyridines; D011759:Pyrrolidines; D012106:Research
D000166:Acridines; D001713:Biphenyl Compounds; D004338:Drug Combinations; D005449:Fluorenes; D006016:Glycolates; D006213:Hallucinogens; D008333:Mandelic Acids; D010880:Piperidines; D011725:Pyridines; D011759:Pyrrolidines; C001621:1-ethyl-2-pyrrolidinylmethyl-alpha-phenylcyclopentylglycolate, 1-ethyl-3-piperidyl-alpha-phenylcyclopentylglycolate drug combination; C037938:mandelic acid
ACRIDINES; BEHAVIOR, ANIMAL; BIPHENYL COMPOUNDS; DOGS; EXPERIMENTAL LAB STUDY; FLUORENES; GLYCOLATES; HALLUCINOGENS; MANDELIC ACID; PHARMACOLOGY; PYRIDINES